About Thrive Earlier Detection
Thrive Earlier Detection is a company based in Cambridge (United States) founded in 2019 was acquired by Exact Sciences in October 2020.. Thrive Earlier Detection has raised $367 million across 3 funding rounds from investors including Exact Sciences, Intermountain Healthcare and Brown Advisory. The company has 138 employees as of December 31, 2022. Thrive Earlier Detection operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Cambridge, United States
- Employees 138 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Thrive Earlier Detection Corp
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$367 M (USD)
in 3 rounds
-
Latest Funding Round
$257 M (USD), Series B
Jul 29, 2020
-
Investors
Exact Sciences
& 20 more
-
Employee Count
138
as on Dec 31, 2022
-
Acquired by
Exact Sciences
(Oct 27, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
105 people
Software Development Team
103 people
Screening Team
78 people
Senior Team
62 people
Sales and Marketing
30 people
Data Analysis and Operations Team
29 people
Human Resources and Administration
28 people
Operations Team
23 people
Unlock access to complete
Funding Insights of Thrive Earlier Detection
Thrive Earlier Detection has successfully raised a total of $367M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $257 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $257.0M
-
First Round
First Round
(30 May 2019)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series B - Thrive Earlier Detection | Valuation | Casdin Capital , S32 | |
| Jul, 2019 | Amount | Grant - Thrive Earlier Detection | Valuation |
investors |
|
| May, 2019 | Amount | Series A - Thrive Earlier Detection | Valuation | Third Rock Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Thrive Earlier Detection
Thrive Earlier Detection has secured backing from 21 investors, including venture fund and institutional investors. Prominent investors backing the company include Exact Sciences, Intermountain Healthcare and Brown Advisory. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Thrive Earlier Detection
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Thrive Earlier Detection
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Thrive Earlier Detection Comparisons
Competitors of Thrive Earlier Detection
Thrive Earlier Detection operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Thrive Earlier Detection
Frequently Asked Questions about Thrive Earlier Detection
When was Thrive Earlier Detection founded?
Thrive Earlier Detection was founded in 2019.
Where is Thrive Earlier Detection located?
Thrive Earlier Detection is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Thrive Earlier Detection a funded company?
Thrive Earlier Detection is a funded company, having raised a total of $367M across 3 funding rounds to date. The company's 1st funding round was a Series A of $110M, raised on May 30, 2019.
How many employees does Thrive Earlier Detection have?
As of Dec 31, 2022, the latest employee count at Thrive Earlier Detection is 138.
What does Thrive Earlier Detection do?
Thrive Earlier Detection was founded in 2019 and is based in Cambridge, United States. Operations center on the biotechnology sector, where a blood-based liquid biopsy test is developed for detecting multiple cancers. DNA mutations and protein abnormalities associated with cancer are analyzed through this test. The approach supports treatment by enabling earlier identification in clinical settings.
Who are the top competitors of Thrive Earlier Detection?
Thrive Earlier Detection's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
Who are Thrive Earlier Detection's investors?
Thrive Earlier Detection has 21 investors. Key investors include Exact Sciences, Intermountain Healthcare, Brown Advisory, T. Rowe Price, and HHS.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.